The Premature Labor (Tocolysis) drugs in development market research report provides comprehensive information on the therapeutics under development for Premature Labor (Tocolysis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Premature Labor (Tocolysis). Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Premature Labor (Tocolysis) and features dormant and discontinued products.
GlobalData tracks 15 drugs in development for Premature Labor (Tocolysis) by 14 companies/universities/institutes. The top development phase for Premature Labor (Tocolysis) is preclinical with six drugs in that stage. The Premature Labor (Tocolysis) pipeline has 13 drugs in development by companies and two by universities/ institutes. Some of the companies in the Premature Labor (Tocolysis) pipeline products market are: Dare Bioscience, Osel and University of Tokyo.
The key targets in the Premature Labor (Tocolysis) pipeline products market include Progesterone Receptor, Programmed Cell Death Protein 1, and Prostaglandin F2 Alpha Receptor.
The key mechanisms of action in the Premature Labor (Tocolysis) pipeline product include Progesterone Receptor Agonist with two drugs in Phase II. The Premature Labor (Tocolysis) pipeline products include four routes of administration with the top ROA being Oral and four key molecule types in the Premature Labor (Tocolysis) pipeline products market including Small Molecule, and Biologic.
Premature Labor (Tocolysis) overview
Preterm labor or premature labor is defined as labor that begins before the completion of 36 weeks of pregnancy. Symptoms include sensation of pelvic or lower abdominal pressure, mild abdominal cramps, diarrhea, vaginal spotting or bleeding, and constant low, dull backache. Treatment includes corticosteroids and tocolytics.
For a complete picture of Premature Labor (Tocolysis)’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
